Abstract
Prebiotics are non-digestible oligosaccharides that promote the growth of beneficial gut microbes, but it is unclear whether they also have direct effects on the intestinal mucosal barrier. Here we demonstrate two commercial prebiotics, inulin and short-chain fructo-oligosaccharide (scFOS), when applied onto intestinal epithelia in the absence of microbes, directly promote barrier integrity to prevent pathogen-induced barrier disruptions. We further show that these effects involve the induction of select tight junction (TJ) proteins through a protein kinase C (PKC) δ-dependent mechanism. These results suggest that in the absence of microbiota, prebiotics can directly exert barrier protective effects by activating host cell signaling in the intestinal epithelium, which represents a novel alternative mechanism of action of prebiotics.
Similar content being viewed by others
Introduction
The essential role of the gut microbiota in human health and disease has stimulated increasing interest in therapeutic strategies to alter microbial composition1,2. One such strategy is the use of dietary prebiotics, which are non-digestible food ingredients that resist absorption in the gastrointestinal tract and are fermented by selected intestinal microbes to stimulate the growth and activities of health-promoting gut microbes, including Lactobacilli and Bifidobacteria3.
Fructans are a group of carbohydrates that fall under the definition of prebiotics and include inulin and fructooligosaccharides (FOS), which are plant-derived polysaccharides comprised of fructose monomers connected via β(2-1) glycosidic bonds linked to a terminal glucose residue4. Inulin and FOS differ mainly in chain length, with a degree of polymerization of greater than 10 for inulin and less than 10 for FOS4.
The health-promoting benefits of prebiotics have been attributed mainly to indirect effects through either bifidogenic or anti-adhesive properties2,4,5. Prebiotic fermentation by Lactobacilli and Bifidobacteria results in the production of short-chain fatty acids such as acetate, propionate and butyrate, which create an acidic microenvironment that can antagonize the growth of pathogenic microbes5. Furthermore, specific prebiotics can interfere with pathogen adherence by competitively inhibiting the binding of pathogenic microbes to host receptors6. For example, enteropathogenic Escherichia coli expresses oligosaccharide-binding adhesins that allow the microbe to dock to carbohydrates expressed on the apical epithelial surface7. Galactooligosaccharides mimic these binding motifs to inhibit E. coli attachment to enterocytes7.
Prebiotics may also exert direct effects on the host gut epithelium, but these effects are largely unexplored. This study demonstrates that prebiotics directly act on the intestinal epithelium to elicit specific signaling responses in the absence of microbes. Two commonly used commercial prebiotics, inulin and scFOS, were employed and their effects on barrier function were measured in immortalized gut-derived epithelial cell lines and human intestinal organoids. Addition of both inulin and scFOS maintained epithelial barrier function in the context of epithelial injury caused by a non-invasive human enteric bacterial pathogen, enterohemorrhagic Escherichia coli O157:H7 (EHEC). Chemical inhibitors and functional knockdown studies were employed to show that the protective mechanism was due to prebiotic activation of PKCδ. These results indicate that prebiotics directly modulate gut homeostasis in a microbe-independent manner.
Results
Prebiotics protect the intestinal epithelial barrier from EHEC challenge
To determine barrier function, we measured the transepithelial electrical resistance (TER) of Caco-2Bbe1 monolayers in response to inulin and scFOS with or without EHEC challenge. In the unchallenged state, only inulin, but not scFOS, increased the TER of Caco-2Bbe1 cells (Fig. 1a). In the challenged state, EHEC decreased TER to 13.3 ± 1.6% of baseline, but pre-incubation with either inulin or scFOS attenuated the EHEC-induced decline in TER resulting in post-challenge TER of 49.9 ± 3.7% and 48.9 ± 5.6% for inulin and scFOS, respectively (Fig. 1a). This protection is time-dependent as shown in the time-TER response (Supplementary Fig. 1a) where the effect was maximal at 4–5 h but abolished by 8 h of EHEC exposure – an observation congruous to what we have described previously8. Using this optimal 5 h window, we confirmed TER results using a fluorescein-labeled isothiocyanate (FITC) dextran permeability assay, where both inulin and scFOS-treated cells exhibited reduced dextran permeability after the 5 h EHEC challenge (Fig. 1b). We next evaluated whether enhanced intercellular TJ integrity is responsible for the barrier protective effects of prebiotics. The cellular response to EHEC challenge seen using immunofluorescence microscopy includes the transformation of zona occluden-1 (ZO-1) from continuous, circumferential staining to diffuse, punctate staining (Fig. 1c)9. However, the presence of either inulin or scFOS prevented EHEC-induced redistribution of ZO-1. In comparison, unchallenged but prebiotic-treated cells displayed morphology comparable to untreated control cells.
To compliment the barrier protective effects of inulin and scFOS, we performed the same assays on ex vivo cultured duodenal organoids derived from three individual patients. Unlike cancer-derived epithelial cell lines, organoids are derived from primary stem cells and consist of a heterogeneous cell population with cell-type specific markers which were unaltered by the presence of inulin or scFOS (Supplementary Fig. 1b).When grown on Transwell filter supports, the intestinal organoids form a two-dimensional monolayer with clear cell border demarcations and TJ (ZO-1) expression (Supplementary Fig. 1c). Under these conditions, EHEC challenge did not impact the TER of human intestinal organoids (Fig. 1d, P > 0.05) but significantly increased FITC-dextran permeability (Fig. 1e). Similar to Caco-2Bbe1 cells, pre-incubation of organoids with either inulin or scFOS significantly increased TER during EHEC challenge (Fig. 1d) and prevented the EHEC-mediated increase in FITC dextran permeability (Fig. 1e). Interestingly, in the unchallenged state, scFOS increased TER even though this was not seen in the Caco-2Bbe1 cells. Taken together, these findings indicate a generalized protective response whereby prebiotics directly enhance epithelial barrier integrity to protect against pathogen-induced barrier disruption in physiological models of human gut epithelia.
Prebiotics regulate TJ protein and mRNA levels
To determine whether the enhanced epithelial barrier integrity involved changes in TJ expression, both mRNA and protein levels of claudin-1, ZO-1 and occludin were measured. Neither prebiotic altered claudin-1 mRNA or protein levels (Fig. 2a). ScFOS, but not inulin, increased ZO-1 mRNA expression in EHEC challenged cells and increased ZO-1 protein levels in both unchallenged and challenged cells (Fig. 2b). Inulin and scFOS also increased protein levels of occludin in the absence or presence of EHEC, but without altering occludin mRNA expression (Fig. 2c). This result suggests that prebiotics may directly alter select TJ expressions to affect epithelial barrier function.
Prebiotics impact the host kinome response
To investigate the potential mechanisms mediating prebiotic modulation of barrier function and TJ expression, we measured the effects of scFOS on the host kinome using a 282-peptide immune array to screen for potential pathways10,11. As depicted in Fig. 3a, in 15 minutes of exposure, scFOS induced global shifts in the kinome activity of Caco-2Bbe1 cells. Of the 282 peptides surveyed, scFOS differentially phosphorylated 149 peptides by a fold change of greater than 1.2. To interrogate the function of these kinases, we performed gene enrichment analysis and identified specific clusters of gene ontology categories (Fig. 3b) and immune pathways that were modified (Fig. 3c). Notably, in line with recent reports suggesting glycan modulations of Toll-like Receptors (TLRs)12, kinases involved in MAPK and TLR were highly annotated in our analysis. Inspection of specific kinases involved in TLR signaling revealed 24 differentially phosphorylated kinases (Fig. 3d) whose specific roles in the TLR pathway are presented in Supplementary Fig. 2.
One of the ways in which TLR pathways regulate epithelial barrier is the activation of protein kinase C (PKC)13. The PKC family of serine/threonine kinases has 12 known isoforms that activate various downstream pathways such as mitogen-activated protein kinases (MAPKs)14,15, and participates in a variety of cellular processes14,16,17. Select PKC isoforms, such as α and δ, are highly expressed in the intestinal epithelium isoforms and are involved in the assembly of intercellular TJ13,17. To assess the possible connections between PKC and TLR pathways, we queried all 149 modulated peptides and interrogated their protein interactions with PKC isoform δ using GeneMania18. This analysis revealed 26 peptides (Fig. 3e), 24 of which directly interact with PKCδ in extensive physical or pathway interactions. The functional pathway most highly enriched in this data set was TLR signaling. Taken together, these findings suggest that scFOS induces a TLR-related response in intestinal epithelial cells that may involve a PKC-mediated mechanism.
Inulin and scFOS activate specific PKC isoforms in intestinal epithelial cells
To check whether PKC is involved in prebiotic modulation of barrier function and TJ expression, we measured PKC activity in prebiotic-treated Caco-2Bbe1 cells and intestinal organoids. Using a phospho-panPKC antibody that detects phosphorylation in a broad range of isoforms, we found that inulin and scFOS both induced panPKC phosphorylation in a time- (Fig. 4a) and dose- (Fig. 4b) dependent manner, as well as activating downstream P38 and P44/42 MAPK (ERK1/2) pathways (Supplementary Fig. 3a,b). We also assessed these signaling events in 2D-grown intestinal organoids (Fig. 4a, Supplementary Fig. 3c). While both inulin and scFOS induced MAPK signaling, in contrast to the effects observed using Caco-2Bbe1 cells, the panPKC phosphorylation response to inulin or scFOS was not evident using organoids.
Next, to identify which PKC isoform(s) was targeted by prebiotics, we determined the levels of phosphorylated isoforms α and δ. Following 15 min of exposure, inulin and scFOS induced phosphorylation of PKCδ (Fig. 4c), but not PKCα (Supplementary Fig. 3d). This finding was confirmed using a PKCδ-specific inhibitor rottlerin, which prevented the panPKC phosphorylation induced by either inulin or scFOS (Fig. 4d). Similarly, panPKC phosphorylation was also attenuated by transfecting Caco-2Bbe1 cells with PKCδ siRNA, but not with PKCα siRNA (Fig. 4e, Supplementary Fig. 3e,f). To ensure PKCα was efficiently knocked down by the construct, we measured PKCα levels as shown in Supplementary Fig. 3g. To control for the general effects of osmotic stress, we also compared the PKCδ activation of scFOS (10% w/v) using iso-osmotic controls 10% w/v maltodextrin and 10% w/v lactose (Supplementary Fig. 3h). As shown in the immunoblots, neither of the iso-osmotic controls induced PKCδ activation, suggesting that PKCδ activation was likely a structure-specific response.
PKCδ signaling is required for prebiotic protection of intestinal barrier integrity
To investigate the link between prebiotic barrier effects and PKCδ signaling, we tested the impact of inhibiting PKCδ on the prebiotics’ ability to maintain TER following EHEC challenge. As shown in Fig. 5a,b, prebiotic attenuation of the EHEC-induced drop in TER was blocked by treating cells with the panPKC inhibitor Gö6893, rottlerin or PKCδ siRNA. Rottlerin-treated cells demonstrated greater dextran permeability (Fig. 5c). Loss of TJ ZO-1 organization was also observed in rottlerin-treated cells but not in cells with Gö6893 (Fig. 5d). Next, to compare TJ expression effects, we blocked Caco-2Bbe1 cells with Gö6893 prior to prebiotic exposure and measured ZO-1 and occludin protein levels. Gö6893 (100 nM) prevented scFOS-induced ZO-1 expression, while increases in occludin expression induced by either prebiotic was also prevented by 10 and 100 nM Gö6893 (Fig. 5e). Caco-2Bbe1 cells treated with Gö6893 alone at 1, 10 and 100 nM did not alter expression levels of either ZO-1 or occludin (Supplementary Fig. 4). Taken together, these results indicate that PKCδ activity is required for the protective effects of inulin and scFOS on epithelial barrier integrity.
Discussion
Although it is generally recognized that prebiotics affect human health by altering the gut microbiota5, much less is known about the extent of direct effects on the host mucosal surface2. Previous studies have shown that β(2–1) fructans increase the TER of T84 monolayers, which was hypothesized to be due to PKC signaling19. In the present work, we tested this possibility to provide the first evidence for a direct mechanism whereby prebiotics, agents believed to be mostly inert to the host, activate the PKCδ signal transduction pathway to regulate TJ integrity and mitigate the deleterious effects of EHEC. These results demonstrate a specific and direct host-nutrient interaction and elucidate a novel mechanism whereby prebiotics maintain gut homeostasis to protect the host against challenge by enteric pathogens.
In this study, we showed that the prebiotics inulin and scFOS maintain TER and decrease dextran flux in an EHEC injury model by upregulating occludin and ZO-1 expression. TJs encircle and anchor adjacent cells, and depletion of their expression disrupts the ability of epithelial cells to form a barrier and maintain TER20. Prebiotics reduce gut permeability and facilitate claudin-3 assembly and expression21,22, but the underlying mechanisms have remained unclear. Cani and colleagues previously found that prebiotics increased the expression of both ZO-1 and occludin in mice via a microbe-dependent mechanism21, but the possibility of direct non-microbial mechanism has also been suggested23. We previously identified that atypical PKC isoforms are involved in the signaling responses to EHEC24, we extend these findings by now showing PKC signaling can also be triggered by exposure to dietary prebiotics to alter epithelial barrier and TJ function. This observation was validated through PKC loss-of-function experiments, which abolished the protective effects of prebiotics on epithelial barrier integrity. These findings are supported by previous studies showing that activation of the PKCδ pathway increases TER and promote assembly of ZO-113. Taken together, these results support the emerging theory that in addition to microbial interactions, prebiotics can impact gut homeostasis via direct mechanisms on host signaling pathways.
Traditionally, the antimicrobial properties of prebiotics are attributed to their role as decoy receptors. Bacterial adhesins bind to sugar motifs expressed on the cell membrane and prebiotics bearing such motifs interfere with binding4. However, using immunostaining we previously observed that neither inulin or scFOS affected the formation of attaching and effacing lesions in EHEC-challenged cells8, indicating that physical inhibition was not a major factor in barrier protection. Additionally, our results also demonstrated that changes in TJ expression and TER occurred in the absence of EHEC challenge, which again suggests that the protective effects are independent of bacteria interference. However, our results do not preclude the possibility that prebiotics may also regulate the expression of EHEC virulence factors. In Pseudomonads, for example, FOS reduced the expression of exotoxin A and inhibited NF-κB activation25. Whether inulin and scFOS can regulate the expression of EHEC virulence factors remains an open question. Furthermore, it is not known whether prebiotics induce the expression of antimicrobial peptides such as defensins through the involvement of TLRs. Although we have previously found that neither inulin or scFOS affects the proportion of viable EHEC at 5 h8, further characterization of these effects on bacterial cells is warranted.
Downstream PKC phosphorylation is implicated in ligand activation of several receptors, including G-protein Coupled Receptors (GPCRs) and TLRs13,15,26,27. Similar to the PKC kinetics seen in these pathways13,27, both inulin and scFOS induced maximal PKC phosphorylation and kinome responses at 15 min, suggesting that prebiotics directly activate membrane receptors to elicit signal transduction. The observation that scFOS induced kinome activities across several pathways suggests that PKCδ activation is not a singular event, but rather occurs as part of a global shift in signaling induced by prebiotics. Interestingly, we found kinase activities were significantly enriched in TLR pathways, many of which also interact with PKCδ in pathway and physical interactions. These kinase activities align with our previous work on the expression of inflammatory cytokines/chemokines8, which showed that in the absence of EHEC, scFOS changed the expression of TLR-modulated genes including IL-10, TNF-α, CXCL-8 and CXCL-1. Taken together, these results support a view that prebiotics may be directly activating TLR signaling to alter cytokine/chemokine expressions and the integrity of the epithelial barrier. This is also in line with multiple reports showing that prebiotics induce cytokine and chemokine production in monocytes and intestinal epithelial cells in a TLR2- or TLR4-dependent fashion12,19,28,29,30,31. However, whether PKCδ is the only PKC isoform or the only signal transduction pathway affected is still unclear. One major caveat in these studies is the non-targeted effects of PKCδ siRNA and chemical inhibitors. RNA interference using PKCδ siRNA could produce non-specific effects such as cross-reactivity with other isoforms. Similarly, chemical inhibitors could have non-specific effects and induce cytotoxicity. In addition, as seen in the kinome analyses, numerous signaling mediators were activated by scFOS. Due to the known promiscuity of some of these effector kinases, it is likely that other signal transduction effects are also involved. Careful characterization of these downstream signaling events and their particular relations with tissue inflammation should be the subject of future research.
One interesting observation in our study is the specificity of prebiotic effects, which are not only glycan-specific, but also cell type-specific32. For instance, although EHEC-challenged Caco-2Bbe1 cells and intestinal organoids show consistency in macromolecule fluxes and TER responses, the TER response to scFOS and the extent of panPKC phosphorylation in unchallenged cells was different in the two models. This was not too surprising given the differences in cell types: Caco-2Bbe1 cells are homogenous enterocytes derived from a colorectal cancer, while organoids were derived from non-cancerous duodenal biopsies and contained multiple primary cell types. Prebiotics could well elicit differential effects on tissues across various regions of the intestinal tract, and thus it is likely that diverse mechanisms of action could be responsible for the barrier function effects seen when using transformed cell lines versus primary intestinal organoids. Nevertheless, the data presented herein with the complementary gut model systems demonstrate that in the absence of a functional microbiome, prebiotics do exert direct protective effects on the integrity of the epithelial barrier to mitigate disruption triggered by exposure to an enteric microbial pathogen.
In summary, the findings of this study show that prebiotics modulate host cell signaling to promote epithelial barrier integrity by direct effects on the intestinal mucosa. Such a mechanism is seen in plants where sugars are the main signaling molecules in immune pathways, and act as priming agents to confer resistance against microbial invasion33,34. During fungal infection, for instance, plants release the polysaccharide oligogalacturonide from cell walls to facilitate an innate immune response by activating wall-associated kinases analogous to mammalian TLRs35,36. Similar mechanisms may well be relevant in humans. Today, a prebiotic is a widely recognized functional food with reported benefits in conditions such as obesity37,38 and GI disorders4, but the underlying mechanisms of action are unclear. By demonstrating prebiotic fibers can act as direct signaling molecules in the host intestine, the ramifications are manifold in shaping current thinking about the benefits of dietary fiber that were previously unrecognized.
Methods
Prebiotics
Inulin (Quadra, Burlington, Canada) and scFOS (Nutraflora®, Nutrition GTC, Golden, CO) are inulin-type fructan polymers that differ in chain lengths, where scFOS contains 2–9 degrees of polymerization (DP) of fructose monomers while inulin has a DP of >104. To treat cells, inulin and scFOS (1–15% w/v) were solubilized in pre-warmed, antibiotic-free Dulbecco’s modified Eagle medium for Caco-2Bbe1 cells, or 2D culture medium for intestinal organoids (formulation listed below).
Bacterial culture
EHEC was grown from a frozen stock on Columbia 5% blood agar plates (BBL) overnight at 37 °C. Cultures were prepared from individual colonies in Penassay broth (Gibco, Waltham, MA) and grown statically at 37 °C. Overnight cultures were subcultured into fresh Penassay broth for 3 h, and then added onto cell monolayers at a multiplicity of infection (MOI) of 100:1.
Cell culture and transepithelial electrical resistance
Caco-2Bbe1 cells, a differentiated Caco-2 subclone which attains faster confluency, were purchased from American Type Culture Collection and grown using cell culture conditions as previously described8,24. Cells were harvested with trypsin-EDTA and seeded onto 6.5-mm Transwell filter supports (~1 × 105 cells/insert, Corning, Mississauga, Canada) and maintained for 3–4 d until TER reached >800 Ω cm−2 measured using chopstick electrodes (Millipore, Etobicoke, Canada)9,39. The apical medium was replaced with prebiotic (10% w/v, 16 h), and then challenged with EHEC (5 h). Data are expressed as percentages of TER at baseline relative to untreated wells.
Generation and culturing of human intestinal organoids
Ethics approval for this study was obtained from the Ethics Committee of the University Health Network, Toronto, Canada (protocol #15-9437). Informed consent was obtained from all patients prior to their participation. All methods performed in the study were carried out in accordance with the approved guidelines and regulations, and signed informed written consent was collected from all participants prior to participation in the study. Duodenum tissue resections from patients undergoing pancreatico-duodenectomy (Whipple procedure) were used to culture human intestinal organoids. As previously described40, overlying mucus and the underlying muscular layer were removed and the tissue was cut into 20–30 small pieces (2 mm2) and incubated in 5 mM EDTA in AdvanceSTEM ES Qualified DPBS (HyClone, Thermo Fisher, Walktham, MA) for 1 h at 4 °C on an orbital shaker. Crypts were released by mechanical shaking in 1% fetal bovine serum (FBS) in DPBS and isolated by centrifugation (500 g, 10 min). Crypts were resuspended in Matrigel (BD Biosciences, San Jose, CA) at approximately 250 crypts per 25 μL of Matrigel, plated into individual wells of a 24-well plate and placed at 37 °C for 5 min to polymerize. After Matrigel polymerization, embedded crypts were overlayed with organoids culture medium (described in Supplemental information).
Organoids were maintained by replacing culture medium 2–3 days and passaging 5–10 days at 1:2–4. For passaging, culture medium was aspirated and Matrigel dissolved in ice-cold basal medium (advanced DMEM/F12 supplemented with 10 mM HEPES, 1% GlutaMAX and 1% pen/strep). Organoids were transferred to a 15 mL conical tube and mechanically sheared 10–20 times with a fire-polished glass Pasteur pipette. Sheared organoids were centrifuged and resuspended in cold Matrigel.
Primary human intestinal monolayers
To form intestinal epithelial monolayers, 400–500 human organoids from a 4–6 day old culture (2–3 wells of a 24-well plate per Transwell) were dissociated with mechanical shearing and resuspended in TrypLE Express Enzyme (Thermo Fisher) for 3 min at 37 °C. Trypsinized organoids were sheared again to dissociate into single cells and TrypLE inactivated with basal medium containing 10% FBS. Epithelial cells were resuspended in organoid culture medium and then seeded onto Transwell filter supports coated with 1:40 Matrigel in PBS (~1 h at 37 °C). Cells were left to adhere overnight and organoid medium replaced with 2D culture medium (advanced DMEM/F12 supplemented with 10% FBS, 1% N2, 2% B27, 50 ng/mL epidermal growth factor, 1 μM TGFβi, 10 mM nicotinamide and 10 μM Y-27632). Confluent monolayers formed 4–5 days after seeding.
FITC-dextran flux
Paracellular permeability was measured using fluoresceinated dextran (10 kDa, Life Technologies, Thermo Fisher). Briefly, following final TER measurements (5 h for Caco-2Bbe1 cells, 35 h for intestinal organoids), apical compartments were washed with PBS and replaced with solution containing 100 μg/ml FITC-dextran dissolved in DMEM, and basolateral chambers replaced with fresh DMEM. After 5 h incubation at 37 °C, aliquots from the basolateral compartments were collected and signal intensities measured at 700 nm (emission) using an infrared imaging system (Odyssey®, LI-COR Biosciences, Lincoln, NE). Quantified fluorescence signal intensities were converted to absolute dextran quantities (in nanograms) by using a serial dilution curve.
Immunofluorescence microscopy
Polarized cell monolayers were fixed in paraformaldehyde, permeabilized in 0.1% Triton X-100, blocked with 3% bovine serum albumin (Sigma, St. Louis, MO) and incubated with rabbit anti-ZO-1 antibody (Life Technologies) and goat Alexa fluor 488-conjugated anti-rabbit IgG antibodies (Life Technologies) as described previously8. Cells were then mounted onto glass slides using ProLong mounting solution (Life Technologies) and imaged with a Leica DMI6000B fluorescence microscope and companion DFC 360FX camera (Leica Microsystems, Concord, Canada) with 20x magnification.
Immunoblotting
Cell monolayers were lysed, as previously described24, and lysates separated using SDS-PAGE followed by transfer onto nitrocellulose membranes (BioTrace NT, Ann Arbor, MI). Descriptions of primary antibodies used can be found in the supplemental information. Secondary antibodies (IRDye 680 goat anti-rabbit IgG or IRDye 800 goat anti-mouse IgG) were purchased from Rockland (Limerick, PA). Immunoblots were analyzed using an Odyssey imaging system (LI-COR Biosciences). Densitometry ratios were calculated using ImageJ (NIH, Bethesda, MD). Image intensity of bands was normalized to either GAPDH or non-phosphorylated bands, and expressed as a ratio of the control, which was set at 1.
Transfections
PKCα, PKCδ and scrambled siRNAs were obtained from Santa Cruz (Dallas, TX) and transfected using Oligofectamine 2000 (Thermo Fisher), in accordance with manufacturer’s protocol. Briefly, Caco-2Bbe1 cells were seeded onto 24-well plates (~5 × 104 cells/well) and transfected with siRNA oligomers complex dissolved in OPTI-MEM (Life Technologies) at 10, 20 and 50 pmoles for 48 h prior to experiments. Control cells were treated with scrambled siRNA using equal amounts of OPTI-MEM and Oligofectamine reagents. Verification of siRNA knockdown efficiency was performed by western blotting for PKCα and PKCδ.
Pharmacological inhibitors
Broad spectrum PKC inhibitor Gö6983 and PKCδ-specific inhibitor rottlerin were purchased from Calbiochem (San Diego, CA). Gö6983 inhibits various isoforms of PKC: PKCα (7 nM), PKCβ (7 nM), PKCγ (6 nM), PKCδ (10 nM) and PKCζ (60 nM). Inhibitors were dissolved in DMSO and suspended in tissue culture medium at 1, 10 or 100 nM and 1, 3 or 5 μM for Gö6983 and rottlerin, respectively. Inhibitors were added onto cells for 1 h prior to prebiotic addition without removal or washing. Control cells were treated with vehicle (medium containing 0.5% DMSO). Phorbol myristate acetate (PMA), a chemical inducer of PKC41, was used as a positive control to verify inhibition of PKC phosphorylation by each of the inhibitors.
Kinome array
As described previously10,42, Caco-2Bbe1 cells grown in 6-well plates (~1 × 106 cells) were incubated with or without 10% w/v scFOS for 15 min. Cells were then lysed with lysis buffer containing 20 mM Tris-HCl [pH 7.5], 150 mM NaCl, 1 mM EDTA, 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM Na3VO4, 1 mM NaF, 1 μg/ml leupeptin, 1 g/ml aprotinin, 1 mM PMSF (Sigma). Sample lysates were incubated on the peptide array for 2 h at 37 °C, washed, and submerged in phospho-specific fluorescent ProQ Diamond phosphoprotein stain (Thermo Fisher). Arrays were washed three times to remove excess stain with 20% acetonitrile before a final water wash and prior to being dried and read using a GenePix Professional 4200 A microarray scanner (MDS Analytical Technologies, Toronto, Canada).
Spot intensity signals were collected as mean pixel intensity using local feature background subtraction calculation with default scanner saturation levels. Intensity signals for replicate spots of each peptide were processed to generate a heat map using peptide kinome array-specific analysis methods previously reported10. For analysis of gene ontology functional categories and pathway enrichments, peptides were uploaded onto DAVID and GeneMania for functional annotation and interaction analysis. Heatmap and pathways were generated using GenePattern and Ingenuity Pathway Analysis.
qRT-PCR
Total RNA was isolated using TriZOL (Thermo Fisher) following the manufacturer’s protocol and reverse-transcribed to cDNA using iScript cDNA synthesis kit (Bio-Rad, Mississauga, Canada). qPCR procedure is described in the supplemental information.
Statistics
Results are expressed as means ± SEM derived from at least 3 independent experiments. All statistics were performed using Graphpad Prism 6.0 (Prism) Comparisons of multiple groups were performed using one-way ANOVA with Bonferonni test for post-hoc analysis. Pairwise comparisons were undertaken using the unpaired Student’s t-test. P values less than 0.05 were deemed statistically significant.
Additional Information
How to cite this article: Wu, R. Y. et al. Protein kinase C δ signaling is required for dietary prebiotic-induced strengthening of intestinal epithelial barrier function. Sci. Rep. 7, 40820; doi: 10.1038/srep40820 (2017).
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
Jain, N. & Walker, W. A. Diet and host–microbial crosstalk in postnatal intestinal immune homeostasis. Nat. Rev. Gastroenterol. Hepatol. 12, 14–25 (2014).
Bindels, L. B., Delzenne, N. M., Cani, P. D. & Walter, J. Towards a more comprehensive concept for prebiotics. Nat. Rev. Gastroenterol. Hepatol. 12, 303–310 (2015).
Vandenplas, Y., Zakharova, I. & Dmitrieva, Y. Oligosaccharides in infant formula: more evidence to validate the role of prebiotics. Br. J. Nutr. 113, 1339–1344 (2015).
Vogt, L. et al. Immunological properties of inulin-type fructans. Crit. Rev. Food Sci. Nutr. 55, 414–436 (2015).
Slavin, J. Fiber and prebiotics: mechanisms and health benefits. Nutrients 5, 1417–1435 (2013).
Quintero, M. et al. Adherence inhibition of Cronobacter sakazakii to intestinal epithelial cells by prebiotic oligosaccharides. Curr. Microbiol. 62, 1448–1454 (2011).
Shoaf, K., Mulvey, G. L., Armstrong, G. D. & Hutkins, R. W. Prebiotic galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cells. Infect. Immun. 74, 6920–6928 (2006).
Johnson-Henry, K. C. et al. Short-chain fructo-oligosaccharide and inulin modulate inflammatory responses and microbial communities in Caco2-bbe cells and in a mouse model of intestinal injury. J. Nutr. 144, 1725–1733 (2014).
Donato, K. A. et al. Escherichia albertii and Hafnia alvei are candidate enteric pathogens with divergent effects on intercellular tight junctions. Microb. Pathog. 45, 377–385 (2008).
Trost, B., Kindrachuk, J., Määttänen, P., Napper, S. & Kusalik, A. PIIKA 2: An expanded, web-based platform for analysis of kinome microarray data. PLoS ONE 8, e80837 (2013).
Kindrachuk, J. et al. Ebola Virus Modulates Transforming growth factor signaling and cellular markers of mesenchyme-like transition in hepatocytes. J. Virol. 88, 9877–9892 (2014).
Vogt, L. et al. Immune Modulation by different types of β2→1-fructans is toll-like receptor dependent. PLoS ONE 8, e68367 (2013).
Cario, E., Gerken, G. & Podolsky, D. K. Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology 127, 224–238 (2004).
Ueda, Y. et al. Protein kinase C activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf. J. Biol. Chem. 271, 23512–23519 (1996).
Rahman, A. et al. Protein kinase C-δ regulates thrombin-induced ICAM-1 gene expression in endothelial cells via activation of p38 mitogen-activated protein kinase. Mol. Cell. Biol. 21, 5554–5565 (2001).
Mochly-Rosen, D., Das, K. & Grimes, K. V. Protein kinase C, an elusive therapeutic target? Nat. Rev. Drug Discov. 11, 937–957 (2012).
Suzuki, T. Regulation of intestinal epithelial permeability by tight junctions. Cell. Mol. Life Sci. 70, 631–659 (2013).
Mostafavi, S., Ray, D., Warde-Farley, D., Grouios, C. & Morris, Q. GeneMANIA: a real-time multiple association network integration algorithm for predicting gene function. Genome Biol. 9 Suppl 1, S4 (2008).
Vogt, L. M. et al. Toll-like receptor 2 activation by β2→1-fructans protects barrier function of T84 human intestinal epithelial cells in a chain length-dependent manner. J. Nutr. 144, 1002–1008 (2014).
Van Itallie, C. M., Fanning, A. S., Bridges, A. & Anderson, J. M. ZO-1 stabilizes the tight junction solute barrier through coupling to the perijunctional cytoskeleton. Mol. Biol. Cell 20, 3930–3940 (2009).
Cani, P. D. et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58, 1091–1103 (2009).
Akbari, P. et al. Galacto-oligosaccharides protect the intestinal barrier by maintaining the tight junction network and modulating the inflammatory responses after a challenge with the mycotoxin deoxynivalenol in human Caco-2 Cell monolayers and B6C3F1 mice. J. Nutr. 145, 1604–1613 (2015).
Woting, A. et al. Alleviation of high fat diet-induced obesity by oligofructose in gnotobiotic mice is independent of presence of Bifidobacterium longum. Mol. Nutr. Food Res. 59, 2267–2278 (2015).
Shen-Tu, G., Kim, H., Liu, M., Johnson-Henry, K. C. & Sherman, P. M. Protein kinase C mediates enterohemorrhagic Escherichia coli O157:H7-induced attaching and effacing lesions. Infect. Immun. 82, 1648–1656 (2014).
Ortega-González, M. et al. Fructooligosacharides reduce Pseudomonas aeruginosa PAO1 pathogenicity through distinct mechanisms. PLoS ONE 9, e85772 (2014).
Steinberg, S. F. Distinctive activation mechanisms and functions for protein kinase Cδ. Biochem. J. 384, 449–459 (2004).
Ogasa, M. Gastrin activates nuclear factor kappaB (NFkappaB) through a protein kinase C dependent pathway involving NFkappaB inducing kinase, inhibitor kappaB (IkappaB) kinase, and tumour necrosis factor receptor associated factor 6 (TRAF6) in MKN-28 cells transfected with gastrin receptor. Gut 52, 813–819 (2003).
Lehmann, S. et al. In-vitro evidence for immune-modulatory properties of non-digestible oligosaccharides: direct effect on human monocyte derived dendritic cells. PLOS ONE 10, e0132304 (2015).
Capitán-Cañadas, F. et al. Prebiotic oligosaccharides directly modulate proinflammatory cytokine production in monocytes via activation of TLR4. Mol. Nutr. Food Res. 58, 1098–1110 (2014).
Tsai, C.-C. et al. The immunologically active oligosaccharides isolated from wheatgrass modulate monocytes via Toll-like receptor-2 signaling. J. Biol. Chem. 288, 17689–17697 (2013).
Ortega-González, M. et al. Nondigestible oligosaccharides exert nonprebiotic effects on intestinal epithelial cells enhancing the immune response via activation of TLR4-NFκB. Mol. Nutr. Food Res. 58, 384–393 (2014).
Peshev, D. & Van den Ende, W. Fructans: Prebiotics and immunomodulators. J. Funct. Foods 8, 348–357 (2014).
Gómez-Ariza, J. et al. Sucrose-mediated priming of plant defense responses and broad-spectrum disease resistance by overexpression of the maize pathogenesis-related PRms protein in rice plants. Mol. Plant-Microbe Interact . MPMI 20, 832–842 (2007).
Bolouri Moghaddam, M. R. & Van den Ende, W. Sugars and plant innate immunity. J. Exp. Bot. 63, 3989–3998 (2012).
Brutus, A., Sicilia, F., Macone, A., Cervone, F. & De Lorenzo, G. A domain swap approach reveals a role of the plant wall-associated kinase 1 (WAK1) as a receptor of oligogalacturonides. Proc. Natl. Acad. Sci. 107, 9452–9457 (2010).
Ferrari, S. Oligogalacturonides: plant damage-associated molecular patterns and regulators of growth and development. Front. Plant Sci. 4, (2013).
Delzenne, N. M., Neyrinck, A. M., Bäckhed, F. & Cani, P. D. Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat. Rev. Endocrinol. 7, 639–646 (2011).
Tilg, H. & Gasbarrini, A. Prebiotics for obesity: a small light on the horizon? Gut 62, 1096–1097 (2013).
Sherman, P. M. et al. Probiotics reduce enterohemorrhagic Escherichia coli O157:H7- and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements. Infect. Immun. 73, 5183–5188 (2005).
Sato, T. et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett’s epithelium. Gastroenterology 141, 1762–1772 (2011).
Qian, H., Pipolo, L. & Thomas, W. G. Identification of protein kinase C phosphorylation sites in the angiotensin II (AT1A) receptor. Biochem. J. 343 Pt 3, 637–644 (1999).
Maattanen, P. et al. Divergent immune responses to Mycobacterium avium subsp. paratuberculosis infection correlate with kinome responses at the site of intestinal infection. Infect. Immun. 81, 2861–2872 (2013).
Acknowledgements
We thank Cedojlub Bundalovic-Torma for the assistance with Cytoscape and GeneMania. Research efforts are funded by the Canadian Institutes of Health Research (CIHR MOP-89894 and IOP-92890). RYW is the recipient of a CIHR Vanier Canada Graduate Scholarship. PMS is the recipient of a Canada Research Chair in Gastrointestinal Disease.
Author information
Authors and Affiliations
Contributions
R.Y.W., M.A. and E.S. performed the experiments. M.A., N.J. and C.O. prepared the organoid cultures for figures 1 & 4. E.S., S.N. and P.M. provided the kinome results for figure 3. Data analysis and interpretations were done by R.Y.W., P.M., A.P., S.N., N.J. and P.M.S. R.Y.W., K.J.H. and P.M.S. wrote the manuscript and all of the authors revised and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Competing interests
Research efforts of the authors are supported by Lallemand Health Solutions (Montreal, Quebec, Canada) and PMS has received honoraria from Abbott Nutrition, Mead Johnson Nutritionals and Nestlé Nutrition
Supplementary information
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Wu, R., Abdullah, M., Määttänen, P. et al. Protein kinase C δ signaling is required for dietary prebiotic-induced strengthening of intestinal epithelial barrier function. Sci Rep 7, 40820 (2017). https://doi.org/10.1038/srep40820
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/srep40820